Loading…

Therapeutic Potential of Turmeric in Alzheimer's Disease: Curcumin or Curcuminoids?

Alzheimer's disease (AD) is the most common form of dementia. There is limited choice in modern therapeutics, and drugs available have limited success with multiple side effects in addition to high cost. Hence, newer and alternate treatment options are being explored for effective and safer the...

Full description

Saved in:
Bibliographic Details
Published in:Phytotherapy research 2014-04, Vol.28 (4), p.517-525
Main Authors: Ahmed, Touqeer, Gilani, Anwarul‐Hassan
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c5100-4e44e274262419af4b1efb83f5fa6cfc9b7684e6934ab9ec0f4889e0510ddf783
cites cdi_FETCH-LOGICAL-c5100-4e44e274262419af4b1efb83f5fa6cfc9b7684e6934ab9ec0f4889e0510ddf783
container_end_page 525
container_issue 4
container_start_page 517
container_title Phytotherapy research
container_volume 28
creator Ahmed, Touqeer
Gilani, Anwarul‐Hassan
description Alzheimer's disease (AD) is the most common form of dementia. There is limited choice in modern therapeutics, and drugs available have limited success with multiple side effects in addition to high cost. Hence, newer and alternate treatment options are being explored for effective and safer therapeutic targets to address AD. Turmeric possesses multiple medicinal uses including treatment for AD. Curcuminoids, a mixture of curcumin, demethoxycurcumin, and bisdemethoxycurcumin, are vital constituents of turmeric. It is generally believed that curcumin is the most important constituent of the curcuminoid mixture that contributes to the pharmacological profile of parent curcuminoid mixture or turmeric. A careful literature study reveals that the other two constituents of the curcuminoid mixture also contribute significantly to the effectiveness of curcuminoids in AD. Therefore, it is emphasized in this review that each component of the curcuminoid mixture plays a distinct role in making curcuminoid mixture useful in AD, and hence, the curcuminoid mixture represents turmeric in its medicinal value better than curcumin alone. The progress in understanding the disease etiology demands a multiple‐site‐targeted therapy, and the curcuminoid mixture of all components, each with different merits, makes this mixture more promising in combating the challenging disease. Copyright © 2013 John Wiley & Sons, Ltd.
doi_str_mv 10.1002/ptr.5030
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1544012765</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1513058267</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5100-4e44e274262419af4b1efb83f5fa6cfc9b7684e6934ab9ec0f4889e0510ddf783</originalsourceid><addsrcrecordid>eNqN0l1rFDEUBuAgit1WwV-gA72oN1NPviYTb0pZbSsUrXar4k3IzJ7Y1JnNmsxQ6683y64rCIJX-XrycsIJIU8oHFIA9mI5xEMJHO6RCQWtSyoVv08moCUtBa0_75DdlG4AQDMQD8kO47XitRQTcjm7xmiXOA6-LS7CgIvB264IrpiNsceYd_2iOO5-XqPPy4NUvPIJbcKXxXSM7djn0xC38-Dn6egReeBsl_DxZtwjVyevZ9Oz8vzd6Zvp8XnZylx1KVAIZEqwigmqrRMNRdfU3Elnq9a1ulFVLbDSXNhGYwtO1LVGyJfnc6dqvkeer3OXMXwfMQ2m96nFrrMLDGMyVAoBlKlK_gelHGTNKpXp_l_0JoxxkR-yUkwyVgH9E9jGkFJEZ5bR9zbeGQpm1ROTe2JWPcn06SZwbHqcb-HvJmRQrsGt7_Dun0HmYvZhE7jxPg34Y-tt_GZy_UqaT29PjTibvv9IhTRfsn-29s4GY79Gn8zVJQMq8odQWinGfwE_q6vy</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1512522601</pqid></control><display><type>article</type><title>Therapeutic Potential of Turmeric in Alzheimer's Disease: Curcumin or Curcuminoids?</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Ahmed, Touqeer ; Gilani, Anwarul‐Hassan</creator><creatorcontrib>Ahmed, Touqeer ; Gilani, Anwarul‐Hassan</creatorcontrib><description>Alzheimer's disease (AD) is the most common form of dementia. There is limited choice in modern therapeutics, and drugs available have limited success with multiple side effects in addition to high cost. Hence, newer and alternate treatment options are being explored for effective and safer therapeutic targets to address AD. Turmeric possesses multiple medicinal uses including treatment for AD. Curcuminoids, a mixture of curcumin, demethoxycurcumin, and bisdemethoxycurcumin, are vital constituents of turmeric. It is generally believed that curcumin is the most important constituent of the curcuminoid mixture that contributes to the pharmacological profile of parent curcuminoid mixture or turmeric. A careful literature study reveals that the other two constituents of the curcuminoid mixture also contribute significantly to the effectiveness of curcuminoids in AD. Therefore, it is emphasized in this review that each component of the curcuminoid mixture plays a distinct role in making curcuminoid mixture useful in AD, and hence, the curcuminoid mixture represents turmeric in its medicinal value better than curcumin alone. The progress in understanding the disease etiology demands a multiple‐site‐targeted therapy, and the curcuminoid mixture of all components, each with different merits, makes this mixture more promising in combating the challenging disease. Copyright © 2013 John Wiley &amp; Sons, Ltd.</description><identifier>ISSN: 0951-418X</identifier><identifier>EISSN: 1099-1573</identifier><identifier>DOI: 10.1002/ptr.5030</identifier><identifier>PMID: 23873854</identifier><identifier>CODEN: PHYREH</identifier><language>eng</language><publisher>England: Blackwell Publishing Ltd</publisher><subject>adverse effects ; Alzheimer disease ; Alzheimer Disease - drug therapy ; Animals ; Curcuma - chemistry ; Curcuma longa ; curcumin ; Curcumin - analogs &amp; derivatives ; Curcumin - pharmacology ; Curcumin - therapeutic use ; curcuminoids ; dementia ; Diarylheptanoids ; drugs ; etiology ; Humans ; Molecular Structure ; Phytotherapy ; synergy ; therapeutics ; therapy ; turmeric</subject><ispartof>Phytotherapy research, 2014-04, Vol.28 (4), p.517-525</ispartof><rights>Copyright © 2013 John Wiley &amp; Sons, Ltd.</rights><rights>Copyright © 2014 John Wiley &amp; Sons, Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5100-4e44e274262419af4b1efb83f5fa6cfc9b7684e6934ab9ec0f4889e0510ddf783</citedby><cites>FETCH-LOGICAL-c5100-4e44e274262419af4b1efb83f5fa6cfc9b7684e6934ab9ec0f4889e0510ddf783</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23873854$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ahmed, Touqeer</creatorcontrib><creatorcontrib>Gilani, Anwarul‐Hassan</creatorcontrib><title>Therapeutic Potential of Turmeric in Alzheimer's Disease: Curcumin or Curcuminoids?</title><title>Phytotherapy research</title><addtitle>Phytother. Res</addtitle><description>Alzheimer's disease (AD) is the most common form of dementia. There is limited choice in modern therapeutics, and drugs available have limited success with multiple side effects in addition to high cost. Hence, newer and alternate treatment options are being explored for effective and safer therapeutic targets to address AD. Turmeric possesses multiple medicinal uses including treatment for AD. Curcuminoids, a mixture of curcumin, demethoxycurcumin, and bisdemethoxycurcumin, are vital constituents of turmeric. It is generally believed that curcumin is the most important constituent of the curcuminoid mixture that contributes to the pharmacological profile of parent curcuminoid mixture or turmeric. A careful literature study reveals that the other two constituents of the curcuminoid mixture also contribute significantly to the effectiveness of curcuminoids in AD. Therefore, it is emphasized in this review that each component of the curcuminoid mixture plays a distinct role in making curcuminoid mixture useful in AD, and hence, the curcuminoid mixture represents turmeric in its medicinal value better than curcumin alone. The progress in understanding the disease etiology demands a multiple‐site‐targeted therapy, and the curcuminoid mixture of all components, each with different merits, makes this mixture more promising in combating the challenging disease. Copyright © 2013 John Wiley &amp; Sons, Ltd.</description><subject>adverse effects</subject><subject>Alzheimer disease</subject><subject>Alzheimer Disease - drug therapy</subject><subject>Animals</subject><subject>Curcuma - chemistry</subject><subject>Curcuma longa</subject><subject>curcumin</subject><subject>Curcumin - analogs &amp; derivatives</subject><subject>Curcumin - pharmacology</subject><subject>Curcumin - therapeutic use</subject><subject>curcuminoids</subject><subject>dementia</subject><subject>Diarylheptanoids</subject><subject>drugs</subject><subject>etiology</subject><subject>Humans</subject><subject>Molecular Structure</subject><subject>Phytotherapy</subject><subject>synergy</subject><subject>therapeutics</subject><subject>therapy</subject><subject>turmeric</subject><issn>0951-418X</issn><issn>1099-1573</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNqN0l1rFDEUBuAgit1WwV-gA72oN1NPviYTb0pZbSsUrXar4k3IzJ7Y1JnNmsxQ6683y64rCIJX-XrycsIJIU8oHFIA9mI5xEMJHO6RCQWtSyoVv08moCUtBa0_75DdlG4AQDMQD8kO47XitRQTcjm7xmiXOA6-LS7CgIvB264IrpiNsceYd_2iOO5-XqPPy4NUvPIJbcKXxXSM7djn0xC38-Dn6egReeBsl_DxZtwjVyevZ9Oz8vzd6Zvp8XnZylx1KVAIZEqwigmqrRMNRdfU3Elnq9a1ulFVLbDSXNhGYwtO1LVGyJfnc6dqvkeer3OXMXwfMQ2m96nFrrMLDGMyVAoBlKlK_gelHGTNKpXp_l_0JoxxkR-yUkwyVgH9E9jGkFJEZ5bR9zbeGQpm1ROTe2JWPcn06SZwbHqcb-HvJmRQrsGt7_Dun0HmYvZhE7jxPg34Y-tt_GZy_UqaT29PjTibvv9IhTRfsn-29s4GY79Gn8zVJQMq8odQWinGfwE_q6vy</recordid><startdate>201404</startdate><enddate>201404</enddate><creator>Ahmed, Touqeer</creator><creator>Gilani, Anwarul‐Hassan</creator><general>Blackwell Publishing Ltd</general><general>Wiley Subscription Services, Inc</general><scope>FBQ</scope><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>7QP</scope><scope>7QR</scope><scope>7TK</scope><scope>7TM</scope><scope>8FD</scope><scope>FR3</scope><scope>K9.</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope></search><sort><creationdate>201404</creationdate><title>Therapeutic Potential of Turmeric in Alzheimer's Disease: Curcumin or Curcuminoids?</title><author>Ahmed, Touqeer ; Gilani, Anwarul‐Hassan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5100-4e44e274262419af4b1efb83f5fa6cfc9b7684e6934ab9ec0f4889e0510ddf783</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>adverse effects</topic><topic>Alzheimer disease</topic><topic>Alzheimer Disease - drug therapy</topic><topic>Animals</topic><topic>Curcuma - chemistry</topic><topic>Curcuma longa</topic><topic>curcumin</topic><topic>Curcumin - analogs &amp; derivatives</topic><topic>Curcumin - pharmacology</topic><topic>Curcumin - therapeutic use</topic><topic>curcuminoids</topic><topic>dementia</topic><topic>Diarylheptanoids</topic><topic>drugs</topic><topic>etiology</topic><topic>Humans</topic><topic>Molecular Structure</topic><topic>Phytotherapy</topic><topic>synergy</topic><topic>therapeutics</topic><topic>therapy</topic><topic>turmeric</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ahmed, Touqeer</creatorcontrib><creatorcontrib>Gilani, Anwarul‐Hassan</creatorcontrib><collection>AGRIS</collection><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Phytotherapy research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ahmed, Touqeer</au><au>Gilani, Anwarul‐Hassan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Therapeutic Potential of Turmeric in Alzheimer's Disease: Curcumin or Curcuminoids?</atitle><jtitle>Phytotherapy research</jtitle><addtitle>Phytother. Res</addtitle><date>2014-04</date><risdate>2014</risdate><volume>28</volume><issue>4</issue><spage>517</spage><epage>525</epage><pages>517-525</pages><issn>0951-418X</issn><eissn>1099-1573</eissn><coden>PHYREH</coden><abstract>Alzheimer's disease (AD) is the most common form of dementia. There is limited choice in modern therapeutics, and drugs available have limited success with multiple side effects in addition to high cost. Hence, newer and alternate treatment options are being explored for effective and safer therapeutic targets to address AD. Turmeric possesses multiple medicinal uses including treatment for AD. Curcuminoids, a mixture of curcumin, demethoxycurcumin, and bisdemethoxycurcumin, are vital constituents of turmeric. It is generally believed that curcumin is the most important constituent of the curcuminoid mixture that contributes to the pharmacological profile of parent curcuminoid mixture or turmeric. A careful literature study reveals that the other two constituents of the curcuminoid mixture also contribute significantly to the effectiveness of curcuminoids in AD. Therefore, it is emphasized in this review that each component of the curcuminoid mixture plays a distinct role in making curcuminoid mixture useful in AD, and hence, the curcuminoid mixture represents turmeric in its medicinal value better than curcumin alone. The progress in understanding the disease etiology demands a multiple‐site‐targeted therapy, and the curcuminoid mixture of all components, each with different merits, makes this mixture more promising in combating the challenging disease. Copyright © 2013 John Wiley &amp; Sons, Ltd.</abstract><cop>England</cop><pub>Blackwell Publishing Ltd</pub><pmid>23873854</pmid><doi>10.1002/ptr.5030</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0951-418X
ispartof Phytotherapy research, 2014-04, Vol.28 (4), p.517-525
issn 0951-418X
1099-1573
language eng
recordid cdi_proquest_miscellaneous_1544012765
source Wiley-Blackwell Read & Publish Collection
subjects adverse effects
Alzheimer disease
Alzheimer Disease - drug therapy
Animals
Curcuma - chemistry
Curcuma longa
curcumin
Curcumin - analogs & derivatives
Curcumin - pharmacology
Curcumin - therapeutic use
curcuminoids
dementia
Diarylheptanoids
drugs
etiology
Humans
Molecular Structure
Phytotherapy
synergy
therapeutics
therapy
turmeric
title Therapeutic Potential of Turmeric in Alzheimer's Disease: Curcumin or Curcuminoids?
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T02%3A39%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Therapeutic%20Potential%20of%20Turmeric%20in%20Alzheimer's%20Disease:%20Curcumin%20or%20Curcuminoids?&rft.jtitle=Phytotherapy%20research&rft.au=Ahmed,%20Touqeer&rft.date=2014-04&rft.volume=28&rft.issue=4&rft.spage=517&rft.epage=525&rft.pages=517-525&rft.issn=0951-418X&rft.eissn=1099-1573&rft.coden=PHYREH&rft_id=info:doi/10.1002/ptr.5030&rft_dat=%3Cproquest_cross%3E1513058267%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c5100-4e44e274262419af4b1efb83f5fa6cfc9b7684e6934ab9ec0f4889e0510ddf783%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1512522601&rft_id=info:pmid/23873854&rfr_iscdi=true